Status:
RECRUITING
Childhood Outcomes of Preterm Brain Abnormalities
Lead Sponsor:
Children's Hospital Los Angeles
Collaborating Sponsors:
University of Pittsburgh
Arizona State University
Conditions:
Premature Birth
Neurodevelopmental Disorders
Eligibility:
All Genders
Up to 8 years
Brief Summary
Prematurely born children are at higher risk of cognitive impairments and behavioral disorders than full-term children. There is growing evidence of significant volumetric and shape abnormalities in s...
Detailed Description
The last months of pregnancy are particularly important for the development of the child's brain, and the consequences of premature birth on its development can be substantial. Prematurely born childr...
Eligibility Criteria
Inclusion
- Preterm birth (Gestational Age 21-36 weeks)
- English or Spanish speaking families
- PVL and Grade I and II IVH will be considered
Exclusion
- Shunt
- Intubation, Cpap, Nasal Ventilation
- Chromosomal/Genetic abnormalities
- Mitochondrial/Metabolic Diseases
- Treatment for extracorporeal membrane oxygenation (ECMO)
- Grade III and IV IVH (optional)
Key Trial Info
Start Date :
March 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03410810
Start Date
March 1 2018
End Date
August 1 2025
Last Update
April 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital Los Angeles
Los Angeles, California, United States, 90027